Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameek Roychowdhury

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2020
Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal CancerChristina Wu, Terence M Williams, Ryan Robb, et al.
NPJ Precision Oncology|September 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancerLeah Stein, Karthikeyan Murugesan, Julie W Reeser, et al.
Familial Cancer|June 17, 2022
Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptakeMitchell L Ramsey, Jewel Tomlinson, Rachel Pearlman, et al.
Journal of the National Cancer Institute|October 7, 2004
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorderSameek Roychowdhury, Robert A Baiocchi, Srinivas Vourganti, et al.
Thyroid : Official Journal of the American Thyroid Association|February 13, 2019
Microsatellite Instability Occurs in a Subset of Follicular Thyroid CancersLuke K Genutis, Jerneja Tomsic, Ralf A Bundschuh, et al.
Leukemia & Lymphoma|September 19, 2017
Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemiaLeslie A Andritsos, Nicole R Grieselhuber, Mirela Anghelina, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsyMelanie A Krook, Russell Bonneville, Hui-Zi Chen, et al.
Molecular Cancer Therapeutics|January 9, 2020
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion CholangiocarcinomaMelanie A Krook, Alexandria Lenyo, Max Wilberding, et al.
JTO Clinical and Research Reports|September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research AutopsyHui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Genome Medicine|November 6, 2016
Somatic cancer variant curation and harmonization through consensus minimum variant level dataDeborah I Ritter, Sameek Roychowdhury, Angshumoy Roy, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2020
Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal CancerChristina Wu, Terence M Williams, Ryan Robb, et al.
NPJ Precision Oncology|September 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancerLeah Stein, Karthikeyan Murugesan, Julie W Reeser, et al.
Familial Cancer|June 17, 2022
Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptakeMitchell L Ramsey, Jewel Tomlinson, Rachel Pearlman, et al.
Journal of the National Cancer Institute|October 7, 2004
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorderSameek Roychowdhury, Robert A Baiocchi, Srinivas Vourganti, et al.
Thyroid : Official Journal of the American Thyroid Association|February 13, 2019
Microsatellite Instability Occurs in a Subset of Follicular Thyroid CancersLuke K Genutis, Jerneja Tomsic, Ralf A Bundschuh, et al.
Leukemia & Lymphoma|September 19, 2017
Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemiaLeslie A Andritsos, Nicole R Grieselhuber, Mirela Anghelina, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsyMelanie A Krook, Russell Bonneville, Hui-Zi Chen, et al.
Molecular Cancer Therapeutics|January 9, 2020
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion CholangiocarcinomaMelanie A Krook, Alexandria Lenyo, Max Wilberding, et al.
JTO Clinical and Research Reports|September 30, 2021
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research AutopsyHui-Zi Chen, Russell Bonneville, Anoosha Paruchuri, et al.
Genome Medicine|November 6, 2016
Somatic cancer variant curation and harmonization through consensus minimum variant level dataDeborah I Ritter, Sameek Roychowdhury, Angshumoy Roy, et al.
Pageof 8